The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHG.L Regulatory News (GHG)

  • There is currently no data for GHG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Possible offer by Georgia Capital PLC

15 Apr 2020 07:00

RNS Number : 6537J
Georgia Healthcare Group PLC
15 April 2020
 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE AND THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE EVEN IF THE PRE-CONDITION REFERRED TO BELOW IS SATISFIED OR WAIVED.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 

Georgia Healthcare Group PLC (LSE: GHG)

 

("GHG" or "the Company")

 

Possible offer by Georgia Capital PLC for Georgia Healthcare Group PLC

 

GHG and Georgia Capital PLC ("GCAP") announce that they are in discussions with respect to an all share offer by GCAP for the issued and to be issued share capital of GHG not already held by GCAP, to be implemented by way of a takeover offer, where GHG shareholders would receive 1 share in GCAP for every 5.22 shares of GHG held ("Possible Offer"), the same exchange ratio as offered by GCAP to GHG shareholders in November 2019, an exchange facility ("Exchange Facility") that was substantially oversubscribed.

 

It is a pre-condition of the Possible Offer that the independent directors of GHG ("Independent Directors") will unanimously recommend the Possible Offer should it proceed. The Independent Directors consider GHG to be undervalued by the market, but recognise the substantial shareholder participation in the recent Exchange Facility; GHG's limited free float and share liquidity, and the nature of the all share Possible Offer which would allow existing shareholders of GHG to continue benefiting from exposure to Georgian healthcare, as GCAP shareholders. Therefore, in these circumstances, and having considered the terms of the Possible Offer carefully, the Independent Directors have confirmed to GCAP that, if it makes an offer on these terms, they intend to recommend that GHG shareholders accept that offer ("Offer").

 

While the above pre-condition may be waived, there can be no certainty that any Offer will be made, even if it is satisfied or waived. If an Offer is made, in addition to the terms and conditions that are typical for a transaction of this nature, it will be a condition of any Offer that GCAP shareholders approve the Offer in a general meeting. A further announcement will be made in due course.

 

As a consequence of this announcement an "offer period" has now commenced in respect of GHG in accordance with the rules of the Code. The attention of GHG and GCAP shareholders is drawn to the disclosure requirements of Rule 8 of the Code, which are summarised below.

 

The Independent Directors note that, on 18 November 2019, GCAP announced (in accordance with Rule 2.8 of the Code) that it did not intend to make an offer for GHG within six months of the date of that announcement except in certain circumstances, which included with the agreement of the GHG board. As a result of that announcement, GCAP was subject to the restrictions imposed by Rule 2.8 of the Code for a period of six months, save in the event that the Board of GHG agreed to them being set aside. The six month period prescribed by Rule 2.8 of the Code ends on 19 May 2020 (the "Restricted Period"). The Independent Directors confirm that they have agreed to the restrictions imposed on GCAP by Rule 2.8 of the Code being set aside to enable the discussions regarding the Possible Offer to take place.

In accordance with Paragraph 3 of Practice Statement 28, published by the Panel Executive entitled "Rules 2.8 and 35.1 - Entering Into Talks During a Restricted Period", until such time as the Restricted Period has expired, GCAP is not required by Rule 2.6(a) of the Code to specify a deadline by which GCAP must either announce a firm intention to make an offer in accordance with Rule 2.7 of the Code or to announce it does not intend to make an Offer. This is because GCAP is still subject to the restrictions imposed by Rule 2.8 of the Code until the end of the Restricted Period and, as a result, GHG is able to terminate the discussions with GCAP any time, at which point the restrictions set out in Rule 2.8 would be re-imposed on GCAP for the remainder of the Restricted Period and GHG would announce the same. However, if, at the expiry of the Restricted Period, discussions between the parties are still ongoing and GCAP has not announced (i) its firm intention to make an offer in accordance with Rule 2.7 of the Code, or, (ii) that it does not intend to make an Offer, then the Independent Directors, in accordance with the Code, will announce the date and time by which it must do so, which will be 5.00 pm on the 28th day following the end of the Restricted Period, being 16 June 2020.

 

In accordance with Rule 2.9 of the Code, GHG confirms that, as at the close of business on 14 April 2020, it has 131,681,820 ordinary shares of one pence each in issue and admitted to trading on Main Market of the London Stock Exchange under the UK ISIN code GB00BYSS4K11.

 

In accordance with Rule 2.9 of the Code, GCAP confirms that, as at the close of business on 14 April 2020, it has 40,169,775 ordinary shares of one pence each in issue and admitted to trading on Main Market of the London Stock Exchange under the UK ISIN code GB00BF4HYV08.

 

For the purposes of Rule 2.5(a) of the Code, GCAP has reserved the right to make an offer on less favourable terms than those set out in this announcement with the agreement or recommendation of the Independent Directors. Shareholders should note that whilst GHG has no current plans to declare a dividend, if it does do so before any Offer becomes or is declared wholly unconditional, GCAP reserves the right to adjust the exchange ratio accordingly.

This announcement has been made with the consent of GCAP.

 

Person releasing this announcement on behalf of GHG: Ketevan Kalandarishvili, Head of Investor Relations and Funding

 

 

Enquiries

 

Georgia Healthcare Group PLC www.ghg.com.ge or contact:

 

Nikoloz Gamkrelidze

Irakli Gogia

Michael Oliver

CEO

CFO

Adviser to the CEO

+995 322 550505 (5077)

+995 322 550505 (5088)

+44 7801 472268

ngamkrelidze@ghg.com.ge

irakligogia@ghg.com.ge

moliver@bgeo.com

 

Investec Bank plc - Financial Adviser and Corporate Broker to GHG 020 7597 5970

Sara Hale

William Godfrey

Tejas Padalkar

 

 

Georgia Capital PLC ir@gcap.ge

Irakli Gilauri, Chairman & CEO

Giorgi Alpaidze, CFO

 

Numis Securities Limited - Financial Adviser to GCAP 0207 260 1000

Hugh Jonathan

George Fry

Vicki Paine

Investec Bank plc ("Investec"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority ("FCA") and Prudential Regulation Authority, is acting for GHG and no one else in connection with the above and will not be responsible to anyone other than GHG for providing the protections offered to clients of Investec nor for giving advice in relation to the subject matter of this announcement or any other matters referred to in this announcement.

 

Numis Securities Limited ("Numis"), which is authorised and regulated in the United Kingdom by the FCA, is acting as Financial Adviser exclusively for GCAP and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than GCAP for providing the protections afforded to clients of Numis, nor for providing advice in relation to any matter referred to herein.

 

Disclosure requirements of the Takeover Code (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An

Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company (i.e. GHG) and (ii) any securities exchange offeror(s) (i.e. GCAP). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s), save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

Publication on website

 

In accordance with Rule 26.1 of the Code, a copy of this announcement will be made available on the GHG's website www.ghg.com.ge by no later than 12 noon on 16 April 2020.

For the avoidance of doubt, the content of the website referred to above is not incorporated into and does not form part of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
OFDFZLLFBZLFBBQ
Date   Source Headline
24th Oct 20167:00 amRNSGHG launches a new ambulatory cluster
10th Oct 20167:00 amRNSGHG Investor Day Notice
12th Sep 20167:00 amRNSGHG signs loan agreement with IFC
24th Aug 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
15th Aug 20167:00 amRNSHalf-year Report
11th Aug 20167:00 amRNSGHG signs loan agreement with Proparco
11th Aug 20167:00 amRNSNotice of Results
9th Aug 20167:00 amRNSGHG launches outpatient and diagnostic centres
8th Aug 20167:00 amRNSSave the date GHG investor day 23 November
1st Aug 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
27th Jul 20164:40 pmRNSSecond Price Monitoring Extn
27th Jul 20164:35 pmRNSPrice Monitoring Extension
20th Jul 20167:00 amRNSGHG announces appointment of corporate brokers
28th Jun 20163:10 pmRNSDirector/PDMR Shareholding
13th Jun 20167:00 amRNSGHG announces appointment of CEO of Imedi L
26th May 20164:26 pmRNSResult of AGM
17th May 20167:00 amRNS1st Quarter Results
16th May 20167:00 amRNSGHG launches a new ambulatory cluster in Tbilisi
13th May 20167:03 amRNSNotice of the first quarter 2016 results
5th May 20167:03 amRNSHealthcare subsidiary completes acquisition of GPC
5th May 20167:00 amRNSGHG announces completion of the acquisition of GPC
25th Apr 20162:16 pmRNSNotice of AGM
14th Apr 20165:58 pmRNSHolding(s) in Company
14th Apr 20167:51 amRNSLaunch of In Vitro Fertilisation service
13th Apr 20165:36 pmRNSHolding(s) in Company
8th Apr 20165:35 pmRNSAnnual Financial Report
7th Apr 20165:37 pmRNSDirector/PDMR Shareholding
16th Mar 20167:04 amRNSGHG announces appointment of Deputy CEO
16th Mar 20167:00 amRNSAcquisition
23rd Feb 20167:00 amRNSGHG buys out minority at major referral hospital
15th Feb 20167:00 amRNSFinal Results
11th Feb 20163:20 pmRNSNotice of Q4 and Full Year Results
13th Jan 20165:29 pmRNSGHG's Reduction of Capital becomes effective
13th Jan 20167:00 amRNSGHG appoint Chief Clinical Officer
30th Dec 20157:00 amRNSGHG launches two ambulatory clusters
23rd Nov 201510:03 amRNSGHG Q3 results announced as part of BGEO's results
23rd Nov 20157:01 amRNSGeorgia Healthcare Group - Stabilisation Notice
12th Nov 20152:38 pmRNSGHG announces Admission to Trading
9th Nov 20155:36 pmRNSPublication of Prospectus
9th Nov 20157:46 amRNSGHG Prospectus Publication correction
9th Nov 20157:16 amRNSStabilisation Notice
9th Nov 20157:00 amRNSPublication of Prospectus
9th Nov 20157:00 amRNSGHG announces the Offering Price for its IPO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.